Applied DNA Sciences Earning Date (APDN)

USA |NASDAQ |USD

APDN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 10, 2022 Jun 2022 - - $-0.46
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 10, 2022 Jun 2022 - - $1.70M

Applied Dna Sciences's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.

APDN Earnings Date & History Chart

APDN Earnings & Revenue Forecast

APDN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 3 $-1.09 $-1.54 $-0.64
Sep 2023 2 $-0.72 $-1.14 $-0.31

APDN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 1 / 0 $-1.14 $-1.09 $-1.09
Sep 2023 0 / 0 $-0.72 $-0.90 $-0.90

APDN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 3 $15.37M $11.82M $22.35M
Sep 2023 2 $19.65M $14.12M $25.18M

APDN Earnings Date & Revenue History

APDN Earnings History

|
Show More
Show More

APDN Revenue History

|
Show More
Show More

Applied Dna Sciences Next Earnings Date & Report

APDN Next Earnings Date & Report Preview: Jun 2022 (FQ)

APDN's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.

Applied Dna Sciences Previous Earnings Dates & Reports

APDN Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Applied Dna Sciences's previous earnings date was May 11, 2022 for its fiscal quarter ended Mar 31, 2022.

APDN Previous Earnings Date & Report Recap: Sep 2021 (FY)

Applied Dna Sciences's previous annual earnings date was Dec 9, 2021 for its fiscal year ended Sep 30, 2021.

APDN's earnings per share (EPS) was $-2.07, missing the consensus analysts forecast of $-1.85 by 11.89% , and higher than the previous year's EPS (Sep 2020) by -37.65%.

Revenues were $9.03M, better than the forecast of $8.28M by 9.03%, and up by 367.40% from previous year's revenue.

The company reported a net income of $-14.29M.

Applied Dna Sciences reported a free cash flow of $-15.94M for its fiscal year, compared to $-12.21M a year ago.